Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Seagen Inc. (SGEN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Seagen Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1060736.
Total stock buying since 2014: $1,160,479,679.
Total stock sales since 2014: $1,004,689,522.
Total stock option exercises since 2014: $71,753,696.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 392,914 | $73,193,732 | 322,898 | $16,265,420 |
| 2022 | 0 | $0 | 250,716 | $37,014,358 | 234,844 | $7,144,665 |
| 2021 | 0 | $0 | 968,655 | $156,502,918 | 465,023 | $11,080,930 |
| 2020 | 0 | $0 | 3,776,313 | $607,190,520 | 685,142 | $14,851,091 |
| 2019 | 0 | $0 | 532,740 | $44,228,990 | 430,833 | $6,089,430 |
| 2018 | 5,306,804 | $275,895,222 | 375,703 | $24,277,576 | 373,126 | $4,469,898 |
| 2017 | 0 | $0 | 425,707 | $24,086,518 | 375,862 | $4,731,181 |
| 2016 | 6,200,638 | $257,974,072 | 373,779 | $18,628,401 | 407,265 | $4,207,373 |
| 2015 | 9,422,008 | $389,855,263 | 381,027 | $15,900,526 | 277,285 | $2,245,552 |
| 2014 | 7,019,620 | $236,755,122 | 89,351 | $3,665,983 | 86,333 | $668,156 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-03 | Simpson Todd E (Chief Financial Officer) | Sale | 40,232 | 185.00 | 7,442,920 |
| 2021-11-03 | Simpson Todd E (Chief Financial Officer) | Option Ex | 40,232 | 44.09 | 1,773,828 |
| 2021-11-01 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 2,156 | 46.37 | 99,973 |
| 2021-11-01 | Liu Jean I (GC/EVP, Leg Afairs) | Sale | 34,876 | 176.13 | 6,142,709 |
| 2021-11-01 | Liu Jean I (GC/EVP, Leg Afairs) | Option Ex | 34,876 | 35.95 | 1,253,792 |
| 2021-10-29 | Simpson Todd E (Chief Financial Officer) | Sale | 33,564 | 180.00 | 6,041,520 |
| 2021-10-29 | Simpson Todd E (Chief Financial Officer) | Option Ex | 33,564 | 41.04 | 1,377,466 |
| 2021-09-08 | Himes Vaughn B (Chief Technical Officer) | Sale | 6,000 | 150.00 | 900,000 |
| 2021-09-08 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 6,000 | 26.10 | 156,600 |
| 2021-08-31 | Romp Charles R (EVP, Commercial) | Sale | 1,133 | 167.52 | 189,795 |
| 2021-08-31 | Dansey Roger D (Chief Medical Officer) | Sale | 4,611 | 167.52 | 772,416 |
| 2021-08-31 | Himes Vaughn B (Chief Technical Officer) | Sale | 3,584 | 167.52 | 600,377 |
| 2021-08-31 | Liu Jean I (GC/EVP, Legal Affairs) | Sale | 3,648 | 167.52 | 611,098 |
| 2021-08-31 | Simpson Todd E (Chief Financial Officer) | Sale | 3,987 | 167.52 | 667,886 |
| 2021-08-31 | Siegall Clay B (President and CEO) | Sale | 24,783 | 168.37 | 4,169,429 |
| 2021-08-30 | Siegall Clay B (President and CEO) | Sale | 35,706 | 167.21 | 5,970,221 |
| 2021-08-27 | Siegall Clay B (President and CEO) | Sale | 14,294 | 169.51 | 2,422,975 |
| 2021-08-16 | Romp Charles R (EVP, Commercial) | Sale | 777 | 154.55 | 120,088 |
| 2021-08-16 | Dansey Roger D (Chief Medical Officer) | Sale | 1,657 | 154.55 | 256,095 |
| 2021-08-16 | Himes Vaughn B (Chief Technical Officer) | Sale | 658 | 154.55 | 101,696 |
| 2021-08-16 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 718 | 154.55 | 110,969 |
| 2021-08-16 | Simpson Todd E (Chief Financial Officer) | Sale | 533 | 154.55 | 82,377 |
| 2021-08-16 | Siegall Clay B (President & CEO) | Sale | 2,789 | 154.55 | 431,051 |
| 2021-08-13 | Dansey Roger D (Chief Medical Officer) | Sale | 10,000 | 156.91 | 1,569,150 |
| 2021-08-06 | Siegall Clay B (President & CEO) | Sale | 5,793 | 159.86 | 926,068 |
| 2021-08-06 | Siegall Clay B (President & CEO) | Option Ex | 5,793 | 15.46 | 89,559 |
| 2021-08-05 | Siegall Clay B (President & CEO) | Sale | 23,560 | 163.42 | 3,850,245 |
| 2021-08-05 | Siegall Clay B (President & CEO) | Option Ex | 23,560 | 15.46 | 364,237 |
| 2021-07-02 | Romp Charles R (EVP, Commercial) | Sale | 703 | 158.41 | 111,362 |
| 2021-07-02 | Siegall Clay B (President and CEO) | Sale | 15,268 | 156.93 | 2,396,053 |
| 2021-07-02 | Siegall Clay B (President and CEO) | Option Ex | 15,268 | 15.46 | 236,043 |
| 2021-07-01 | Siegall Clay B (President and CEO) | Sale | 14,085 | 157.83 | 2,223,077 |
| 2021-07-01 | Siegall Clay B (President and CEO) | Option Ex | 14,085 | 15.46 | 217,754 |
| 2021-06-16 | Dansey Roger D (Chief Medical Officer) | Sale | 25,109 | 152.22 | 3,822,041 |
| 2021-06-07 | Himes Vaughn B (Chief Technical Officer) | Sale | 1,303 | 150.00 | 195,450 |
| 2021-06-07 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 1,303 | 26.10 | 34,008 |
| 2021-06-03 | Siegall Clay B (President and CEO) | Sale | 29,353 | 144.89 | 4,252,868 |
| 2021-06-03 | Siegall Clay B (President and CEO) | Option Ex | 29,353 | 15.46 | 453,797 |
| 2021-05-17 | Romp Charles R (EVP, Commercial) | Sale | 334 | 145.95 | 48,746 |
| 2021-05-14 | Baker Julian (Director) | Option Ex | 35,000 | 19.02 | 665,700 |
| 2021-05-11 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 1,061 | 140.00 | 148,540 |
| 2021-05-06 | Siegall Clay B (President and CEO) | Sale | 29,353 | 135.05 | 3,964,122 |
| 2021-05-06 | Siegall Clay B (President and CEO) | Option Ex | 29,353 | 15.46 | 453,797 |
| 2021-04-09 | Siegall Clay B (President and CEO) | Sale | 12,602 | 142.71 | 1,798,393 |
| 2021-04-09 | Siegall Clay B (President and CEO) | Option Ex | 12,602 | 15.46 | 194,826 |
| 2021-04-08 | Siegall Clay B (President and CEO) | Sale | 16,751 | 145.85 | 2,443,099 |
| 2021-04-08 | Siegall Clay B (President and CEO) | Option Ex | 16,751 | 15.46 | 258,970 |
| 2021-03-04 | Siegall Clay B (President and CEO) | Sale | 29,353 | 146.22 | 4,292,142 |
| 2021-03-04 | Siegall Clay B (President and CEO) | Option Ex | 29,353 | 15.46 | 453,797 |
| 2021-03-02 | Himes Vaughn B (Chief Technical Officer) | Sale | 12,000 | 153.25 | 1,838,964 |
| 2021-03-02 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 12,000 | 15.46 | 185,520 |
| 2021-02-17 | Liu Jean I (GC/EVP, Leg Affairs) | Option Ex | 4,846 | 42.54 | 206,148 |
| 2021-02-04 | Siegall Clay B (President and CEO) | Sale | 29,353 | 165.03 | 4,844,243 |
| 2021-02-04 | Siegall Clay B (President and CEO) | Option Ex | 29,353 | 15.46 | 453,797 |
| 2021-01-15 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 5,000 | 180.00 | 900,000 |
| 2021-01-15 | Liu Jean I (GC/EVP, Leg Affairs) | Option Ex | 5,000 | 35.95 | 179,750 |
| 2021-01-07 | Siegall Clay B (President and CEO) | Sale | 29,353 | 171.92 | 5,046,250 |
| 2021-01-07 | Siegall Clay B (President and CEO) | Option Ex | 29,353 | 15.46 | 453,797 |
| 2020-12-18 | Simpson Todd E (Chief Financial Officer) | Sale | 33,669 | 200.00 | 6,733,800 |
| 2020-12-18 | Simpson Todd E (Chief Financial Officer) | Option Ex | 34,773 | 35.70 | 1,241,396 |
| 2020-12-16 | Liu Jean I (GC/EVP, Leg Affairs) | Option Ex | 1,624 | 35.95 | 58,382 |
| 2020-12-14 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 5,000 | 195.97 | 979,860 |
| 2020-12-14 | Liu Jean I (GC/EVP, Leg Affairs) | Option Ex | 5,000 | 35.95 | 179,750 |
| 2020-12-07 | Himes Vaughn B (Chief Technical Officer) | Sale | 8,000 | 181.90 | 1,455,160 |
| 2020-12-07 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 12,761 | 33.30 | 424,979 |
| 2020-12-07 | Siegall Clay B (President and CEO) | Sale | 15,723 | 180.81 | 2,842,844 |
| 2020-12-07 | Siegall Clay B (President and CEO) | Option Ex | 15,723 | 15.46 | 243,077 |
| 2020-12-04 | Siegall Clay B (President and CEO) | Sale | 21,732 | 179.59 | 3,902,741 |
| 2020-12-04 | Siegall Clay B (President and CEO) | Option Ex | 21,732 | 15.46 | 335,976 |
| 2020-12-03 | Romp Charles R (EVP, Commercial) | Sale | 7,666 | 179.30 | 1,374,513 |
| 2020-12-03 | Romp Charles R (EVP, Commercial) | Option Ex | 7,666 | 39.15 | 300,123 |
| 2020-12-03 | Siegall Clay B (President and CEO) | Sale | 21,253 | 178.63 | 3,796,529 |
| 2020-12-03 | Siegall Clay B (President and CEO) | Option Ex | 21,253 | 15.46 | 328,571 |
| 2020-12-01 | Romp Charles R (EVP, Commercial) | Sale | 6,000 | 179.09 | 1,074,540 |
| 2020-12-01 | Romp Charles R (EVP, Commercial) | Option Ex | 6,000 | 39.15 | 234,900 |
| 2020-11-19 | Gryska David W (Director) | Sale | 15,000 | 173.72 | 2,605,875 |
| 2020-11-19 | Gryska David W (Director) | Option Ex | 15,000 | 19.02 | 285,300 |
| 2020-11-05 | Simpson Todd E (Chief Financial Officer) | Sale | 7,509 | 180.37 | 1,354,383 |
| 2020-11-05 | Gryska David W (Director) | Sale | 4,500 | 180.60 | 812,700 |
| 2020-11-04 | Romp Charles R (EVP, Commercial) | Sale | 14,079 | 180.81 | 2,545,567 |
| 2020-11-04 | Romp Charles R (EVP, Commercial) | Option Ex | 14,079 | 39.89 | 561,625 |
| 2020-11-04 | Dansey Roger D (Chief Medical Officer) | Sale | 7,661 | 177.03 | 1,356,249 |
| 2020-11-03 | Romp Charles R (EVP, Commercial) | Sale | 6,061 | 171.75 | 1,040,994 |
| 2020-11-03 | Romp Charles R (EVP, Commercial) | Option Ex | 5,197 | 20.01 | 103,976 |
| 2020-11-03 | Lippman Marc E (Director) | Sale | 142,090 | 168.38 | 23,925,540 |
| 2020-11-03 | Lippman Marc E (Director) | Option Ex | 62,780 | 35.23 | 2,211,676 |
| 2020-11-02 | Romp Charles R (EVP, Commercial) | Sale | 13,001 | 166.90 | 2,169,866 |
| 2020-11-02 | Welch Daniel G (Director) | Sale | 58,750 | 166.28 | 9,768,832 |
| 2020-11-02 | Welch Daniel G (Director) | Option Ex | 49,500 | 26.02 | 1,287,891 |
| 2020-09-21 | Liu Jean I (GC/EVP, Leg Affairs) | Option Ex | 9,954 | 37.55 | 373,772 |
| 2020-09-14 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 11,610 | 170.00 | 1,973,700 |
| 2020-09-09 | Himes Vaughn B (Chief Technical Officer) | Sale | 8,000 | 147.63 | 1,181,064 |
| 2020-09-09 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 8,000 | 15.46 | 123,680 |
| 2020-09-01 | Simpson Todd E (Chief Financial Officer) | Sale | 12,091 | 157.00 | 1,898,311 |
| 2020-08-31 | Romp Charles R (EVP, Commercial) | Sale | 1,133 | 155.69 | 176,401 |
| 2020-08-31 | Dansey Roger D (Chief Medical Officer) | Sale | 4,611 | 155.69 | 717,905 |
| 2020-08-31 | Himes Vaughn B (Chief Technical Officer) | Sale | 3,585 | 155.69 | 558,162 |
| 2020-08-31 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 3,648 | 155.69 | 567,971 |
| 2020-08-31 | Simpson Todd E (Chief Financial Officer) | Sale | 4,187 | 155.69 | 651,890 |
| 2020-08-31 | Siegall Clay B (President and CEO) | Sale | 14,351 | 155.69 | 2,234,364 |
| 2020-08-21 | Siegall Clay B (President and CEO) | Option Ex | 10,299 | 20.78 | 214,013 |
| 2020-08-18 | Romp Charles R (EVP, Commercial) | Sale | 4,027 | 158.17 | 636,942 |
| 2020-08-18 | Himes Vaughn B (Chief Technical Officer) | Sale | 8,054 | 158.17 | 1,273,893 |
| 2020-08-18 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 6,846 | 158.17 | 1,082,824 |
| 2020-08-18 | Simpson Todd E (Chief Financial Officer) | Sale | 9,262 | 158.17 | 1,464,961 |
| 2020-08-18 | Siegall Clay B (President and CEO) | Sale | 27,060 | 158.17 | 4,280,053 |
| 2020-08-17 | Dansey Roger D (Chief Medical Officer) | Sale | 450 | 157.79 | 71,005 |
| 2020-08-10 | Siegall Clay B (President and CEO) | Sale | 28,475 | 156.84 | 4,466,019 |
| 2020-08-10 | Siegall Clay B (President and CEO) | Option Ex | 28,475 | 12.00 | 341,700 |
| 2020-08-03 | Simpson Todd E (Chief Financial Officer) | Sale | 20,000 | 165.93 | 3,318,660 |
| 2020-07-17 | Himes Vaughn B (Chief Technical Officer) | Sale | 8,000 | 179.33 | 1,434,640 |
| 2020-07-17 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 8,000 | 15.46 | 123,680 |
| 2020-07-08 | Siegall Clay B (President and CEO) | Sale | 28,472 | 175.34 | 4,992,195 |
| 2020-07-08 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
| 2020-07-02 | Romp Charles R (EVP, Commercial) | Sale | 712 | 167.49 | 119,252 |
| 2020-07-01 | Simpson Todd E (Chief Financial Officer) | Sale | 11,573 | 168.42 | 1,949,078 |
| 2020-06-19 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 9,877 | 165.00 | 1,629,705 |
| 2020-06-17 | Dansey Roger D (Chief Medical Officer) | Sale | 2,162 | 158.77 | 343,260 |
| 2020-06-16 | Dansey Roger D (Chief Medical Officer) | Sale | 838 | 157.15 | 131,691 |
| 2020-06-15 | Dansey Roger D (Chief Medical Officer) | Sale | 4,984 | 157.15 | 783,235 |
| 2020-06-08 | Siegall Clay B (President and CEO) | Sale | 28,472 | 148.06 | 4,215,450 |
| 2020-06-08 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
| 2020-05-15 | Baker Julian (Director) | Sale | 1,750,000 | 160.00 | 280,000,000 |
| 2020-05-12 | Romp Charles R (EVP, Commercial) | Sale | 6,942 | 166.00 | 1,152,372 |
| 2020-05-12 | Romp Charles R (EVP, Commercial) | Option Ex | 6,942 | 15.46 | 107,323 |
| 2020-05-08 | Romp Charles R (EVP, Commercial) | Sale | 6,942 | 163.02 | 1,131,670 |
| 2020-05-08 | Romp Charles R (EVP, Commercial) | Option Ex | 6,942 | 15.46 | 107,323 |
| 2020-05-08 | Siegall Clay B (President and CEO) | Sale | 28,472 | 161.73 | 4,604,833 |
| 2020-05-08 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
| 2020-05-08 | Baker Julian (Director) | Sale | 500,000 | 158.50 | 79,250,000 |
| 2020-05-07 | Dansey Roger D (Chief Medical Officer) | Sale | 11,912 | 164.50 | 1,959,524 |
| 2020-05-07 | Dansey Roger D (Chief Medical Officer) | Option Ex | 11,912 | 65.11 | 775,590 |
| 2020-05-07 | Baker Julian (Director) | Sale | 168,244 | 164.68 | 27,706,421 |
| 2020-05-06 | Welch Daniel G (Director) | Sale | 15,000 | 165.55 | 2,483,205 |
| 2020-05-06 | Siegall Clay B (President and CEO) | Sale | 25,402 | 165.16 | 4,195,394 |
| 2020-05-06 | Baker Julian (Director) | Sale | 390,072 | 165.25 | 64,457,837 |
| 2020-05-05 | Romp Charles R (EVP, Commercial) | Sale | 5,056 | 166.17 | 840,160 |
| 2020-05-05 | Akkaraju Srinivas (Director) | Sale | 8,500 | 167.26 | 1,421,710 |
| 2020-05-05 | Akkaraju Srinivas (Director) | Option Ex | 8,500 | 20.06 | 170,510 |
| 2020-05-05 | Simpson Todd E (Chief Financial Officer) | Sale | 26,867 | 163.30 | 4,387,461 |
| 2020-05-05 | Simpson Todd E (Chief Financial Officer) | Option Ex | 39,059 | 35.19 | 1,374,486 |
| 2020-05-05 | Welch Daniel G (Director) | Sale | 20,000 | 166.78 | 3,335,700 |
| 2020-05-05 | Siegall Clay B (President and CEO) | Sale | 24,598 | 166.24 | 4,089,245 |
| 2020-05-04 | Simpson Todd E (Chief Financial Officer) | Sale | 14,167 | 147.00 | 2,082,563 |
| 2020-05-04 | Simpson Todd E (Chief Financial Officer) | Option Ex | 14,167 | 12.00 | 170,004 |
| 2020-05-04 | Lippman Marc E (Director) | Sale | 1,000 | 152.03 | 152,030 |
| 2020-04-23 | Baker Julian (Director) | Option Ex | 35,000 | 12.76 | 446,600 |
| 2020-04-08 | Siegall Clay B (President and CEO) | Sale | 28,472 | 120.67 | 3,435,659 |
| 2020-04-08 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
| 2020-03-09 | Siegall Clay B (President and CEO) | Sale | 28,472 | 109.58 | 3,119,904 |
Insider trading activities including stock purchases, stock sales, and option exercises of SGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Seagen Inc. (symbol SGEN, CIK number 1060736) see the Securities and Exchange Commission (SEC) website.